Login to Your Account



OH, HOW THE MONEY ROLLS IN

Dicerna, Celladon debut; class of 2012 IPO Tesaro goes back to the well

By Jennifer Boggs
Managing Editor

Friday, January 31, 2014
In what has now become almost blandly – though happily – routine in the biopharma sector, two more companies went public via initial public offerings (IPOs) Thursday amid a heap of other financings news.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription